Alliqua BioMedical, Inc. (ALQA) financial statements (2020 and earlier)

Company profile

Business Address 100 PINE ST., STE. 500
SAN FRANCISCO, CA 94111
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0926261712
Cash and cash equivalents0926261712
Restricted cash and investments0      
Receivables 033   
Inventory, net of allowances, customer advances and progress billings 023311
Inventory 023311
Prepaid expense1      
Disposal group, including discontinued operation 00    
Other undisclosed current assets1001310
Total current assets:39712332013
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0022212
Intangible assets, net (including goodwill)  24405583
Goodwill  2122140
Intangible assets, net (excluding goodwill)  22283442
Other noncurrent assets0000000
Total noncurrent assets:10254357105
TOTAL ASSETS:3103354903017
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5168652
Accounts payable3123321
Accrued liabilities2045321
Employee-related liabilities     2 
Debt9 1112   
Derivative instruments and hedges, liabilities 000101
Disposal group, including discontinued operation 0     
Business combination, contingent consideration, liability   15 
Other liabilities      0
Other undisclosed current liabilities     (2)0
Total current liabilities:14117201243
Noncurrent Liabilities
Long-term debt and lease obligation1000120 
Long-term debt, excluding current maturities 000120 
Operating lease, liability1
Liabilities, other than long-term debt   21300
Deferred tax liabilities, net  1100
Business combination, contingent consideration, liability   112 
Other undisclosed noncurrent liabilities    030
Total noncurrent liabilities:10022630
Total liabilities:14117223773
Stockholders' equity
Stockholders' equity attributable to parent(11)81632522314
Common stock0000000
Additional paid in capital351671661561489359
Accumulated deficit(46)(158)(150)(124)(96)(70)(45)
Total stockholders' equity:(11)81632522314
TOTAL LIABILITIES AND EQUITY:3103354903017

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues0220181552
Revenue, net382500 
Sublease income0
Cost of revenue(0)(2)(7)(7)(6)(3)(2)
Financial services costs1(1)   
Gross profit:00131292(0)
Operating expenses(7)(6)(39)(43)(37)(27)(20)
Other undisclosed operating loss(0)      
Operating loss:(7)(5)(26)(31)(28)(25)(20)
Nonoperating income (expense)(0)(2)(2)(2)1(0)(2)
Investment income, nonoperating00 0000
Debt instrument, convertible, beneficial conversion feature     11
Interest and debt expense(5)(2)(0)(0)(2)(0)(0)
Loss from continuing operations before equity method investments, income taxes:(12)(9)(29)(33)(29)(25)(22)
Other undisclosed income from continuing operations before income taxes 20020 
Loss from continuing operations before income taxes:(12)(7)(29)(33)(28)(25)(22)
Income tax expense (benefit)  112(0)(0)
Loss from continuing operations:(12)(7)(28)(32)(26)(25)(22)
Income (loss) from discontinued operations0(7)     
Net loss:(12)(14)(28)(32)(26)(25)(22)
Other undisclosed net income (loss) attributable to parent(0)524  0
Net loss attributable to parent:(12)(8)(26)(28)(26)(25)(22)
Preferred stock dividends and other adjustments      (0)
Net loss available to common stockholders, diluted:(12)(8)(26)(28)(26)(25)(22)

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net loss:(12)(14)(28)(32)(26)(25)(22)
Comprehensive loss, net of tax, attributable to parent:(12)(14)(28)(32)(26)(25)(22)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: